Emerging Company Report TV Program Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Emerging Company Report TV Program

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dbmedia who wrote (130)	8/17/1999 9:54:00 AM
From: Micro-Selector	Read Replies (2) of 526

BSDM -- new CEO to lead strategic turnaround ******************************************** Company Press Release BSD Medical Corporation Announces Appointment of New President SALT LAKE CITY, Aug. 17 /PRNewswire/ -- BSD Medical Corporation (OTC Bulletin Board: BSDM - news) today announced the appointment of Hyrum A. Mead as President of BSD Medical Corporation. Mr. Mead will also join BSD's Board of Directors. Paul F. Turner, who was Acting President, will become Senior Vice President and Chief Technology Officer and will retain the position of Chairman of the Board. Mr. Mead has over 25 years of experience in managing complex corporate and engineering issues in the demanding technology industry. He specializes in business and market development, strategic planning, and corporate turnarounds. Mr. Mead's leadership and successful implementation of improvements in operations have led to rapid acceleration of sales and profits for several major companies. Mr. Mead has served as VP of Business Development at ZERO Enclosures, a leading manufacturer in the telecommunications, computer and aerospace industry and as President of Electro Controls, a manufacturer of computer controlled power systems that have significant technological overlaps with the BSD systems. Mr. Mead began his career in sales and marketing with IBM. Paul Turner stated, "Hyrum brings a wealth of relevant experience to BSD. He has a proven track record of increasing corporate earnings through focused product and corporate marketing efforts and strategic mergers. I have great confidence that Hyrum will lead our team and company through a sustained period of progress and growth." Hyrum Mead, stated, "I am delighted to have the opportunity to lead the creative and committed team at BSD. The Company is poised to become a major player in the treatment of cancer. This is a clinically proven treatment and technology with a substantial market. BSD's ability to make a positive impact on the future of cancer therapy has attracted me to this opportunity." BSD Medical Corporation (BSDM) is the leading developer and manufacturer of hyperthermia (heat therapy) systems for cancer therapy and pioneered the non-surgical treatment of benign diseases of the prostate using microwave energy. (For additional information on the Company, please visit BSD Medical Corporation's Web Page: bsdmc.com.) Statements contained in this press release that are not historical facts are forward looking statements, as that item is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties (detailed in the Company's filings with the Securities and Exchange Commission) that could cause actual results to differ materially from estimated results. SOURCE: BSD Medical Corporation

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next